Prescribing for patients with diabetes in the community drug schemes

Irish Medical Journal

Volumn 99, Issue 6, 2006, Pages

  Usher, C ^a   Creed, Lisa ^b   Bennett, Kathleen ^b   Feely, John ^b  

^a ST JAMES S HOSPITAL   (Ireland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INSULIN DERIVATIVE; NITRATE; ORAL ANTIDIABETIC AGENT; DRUG;

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; COHORT ANALYSIS; COMMUNITY; DATA BASE; DIABETES MELLITUS; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; IRELAND; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESCRIPTION; PREVALENCE; SECONDARY PREVENTION; DRUG UTILIZATION; MIDDLE AGED; NATIONAL HEALTH SERVICE; STATISTICS;

AGED; DATABASES; DIABETES MELLITUS; DRUG UTILIZATION; FEMALE; HUMANS; IRELAND; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; STATE MEDICINE;

EID: 33747737958     PISSN: 03323102     EISSN: 03323102     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Maronde RF, Lee PV, McCarron MM, Seibert S. A study of prescribing patterns. Medical Care 1971; 9: 383-395.
2. Ringbaek TJ, Lange P, Viskum K. Geographic variation in long-term oxygen therapy in Denmark: factors related to adherence to guidelines for long-term oxygen therapy. Chest. 2001; 119: 1711-1716.
3. Mantyselka P, Ahonen R, Kumpusalo E, Takala J. Variability in prescribing for musculoskeletal pain in Finnish primary health care. Pharm. World Sci. 2001; 23: 232-236.
4. Bennett KE, Williams D, Feely J. Under-prescribing of cardiovascular therapies for diabetes in primary care. Eur. J. Clin. Pharmacol. 2003; 58:835-841.
5. Williams D, Bennett K, Feely J. The application of prescribing indicators to a primary care prescription database in Ireland. Eur. J. Clin. Pharmacol. 2005; 61: 127-33.
6. Teeling M, Bennett K, Feely J. The influence of guidelines on the use of statins: analysis of prescribing trends 1998-2002. Brit. J. Clin. Pharmacol. 2005; 59: 227-22.
7. Leese B, Bosanquet N. Change in general practice and its effects on service provision in areas with different socioeconomic characteristics. BMJ. 1995; 311:546-50.
8. Hart JT. The inverse care law. 1971 Lancet 1: 405-412.
9. Bennett K, Williams D and Feely J. Inequalities in the prescribing of secondary preventative therapies for Ischaemic Heart Disease in Ireland. Ir Med J 2002; 95:169-172.
10. Department of Health and Children. Quality and Fairness a health system for you. 2001
11. Usher C, Bennett K and Feely J. Regional variation in the prescribing for diabetes and use of secondary preventative therapies in Ireland. Pharmacoepidemiol Drug Saf. 2005 14: 537-544.
12. WHO Collaborating Centre for Drug Statistics. ATC classification system.
13. NcNally PG. Epidemiology of heart disease in type 1 and 2 diabetes. In McNally PG (ed). Diabetes and cardiovascular complications Science, London. 1999, p. 1-7
14. Central Statistics Office, Census, Ireland: Ages and marital status. 2002 2: 18-24.
15. Gray J, Majeed A, Kerry S, Rowlands G. Identifying patients with ischaemic heart disease in general practice: cross sectional study of paper and computerised medical records. BMJ 2000; 321:548-550.
16. Inman WH, Pearce G. Prescriber profile and postmarketing surveillance. Lancet 1993; 342: 1491.
17. Feely J, Chan R, McManus J, O'Shea B. The influence of hospital-based prescribers on prescribing in general practice. Pharmacoeconomics. 1999; 16:175-81.
18. Peay MY, Peay ER. The role of commercial sources in the adoption of a new drug. Soc Sci Med. 1988; 26:1183-1189.
19. Diabetes Care: Securing the Future. A report compiled by the Diabetes Service Development Group, 2002.
20. Bell RA, Camacho F, Goonan K, Duren-Winfield V, Anderson RT, Konen JC, Goff DC Jr. Quality of diabetes care among low-income patients in North Carolina. Am J Prev Med 2001; 2:124-131.
21. Weng C, Coppini DV, Sonksen PH. Geographic and social factors are related to increased morbidity and mortality rates in diabetic patients. Diabet Med 2000; 8:612-617.
22. Smith Susan, Byrne G, Shannon WF, Thompson Chris, O’Leary M, Staines A, Tynan A. The North Dublin Diabetes Shared Care (DiSC) Project: A profile of current diabetes care in Ireland. Ir Med J 2001; 94:240-243.
23. DICE, Diabetes Integrated Evaluation Team. Integrated care for diabetes: clinical, psychosocial and economic evaluation. BMJ 1994; 308:1208-1212.
24. Pringle M Stewart-Evans C, Coupland C, Williams I, Allison S, Sterland J. Influences on control in diabetes mellitus: patient, doctor, practice or delivery of care? BMJ 1993; 306: 630-634.
25. Ryan R, Newnham A, Khunti K, Majeed A. Prevalence of diagnosed diabetes mellitus in general practice in England and Wales, 1994 to 1998. J Epidemiol Comm Health 2002; 56(Suppl 2): A7.
26. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998; 351:1755-1762.